Friday, August 13, 2021 5:08:09 PM
Recent PSTX News
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 12/27/2024 10:28:35 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 12/09/2024 10:26:50 PM
- Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting • PR Newswire (US) • 12/09/2024 05:00:00 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 11/27/2024 12:18:25 PM
- California-Based Biotech Trading over +200% Premarket Following Acquisition Announcement • AllPennyStocks.com • 11/26/2024 02:05:00 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 11/26/2024 11:53:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2024 11:49:33 AM
- Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. • PR Newswire (US) • 11/26/2024 06:10:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 02:15:45 PM
- Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline • PR Newswire (US) • 11/14/2024 02:00:00 PM
- Poseida Therapeutics to Present at Two Upcoming Investor Conferences • PR Newswire (US) • 11/11/2024 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:10:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:07:42 PM
- Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024 • PR Newswire (US) • 11/07/2024 09:05:00 PM
- Poseida Therapeutics to Present Clinical and Preclinical Data on Investigational Allogeneic CAR-T Cell Therapies at SITC 2024 and ASH 2024 • PR Newswire (US) • 11/05/2024 09:05:00 PM
- Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema • PR Newswire (US) • 10/24/2024 12:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/22/2024 07:24:01 PM
- Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche • PR Newswire (US) • 10/17/2024 12:00:00 PM
- MaxCyte Appoints Cynthia Collins to its Board of Directors • GlobeNewswire Inc. • 10/15/2024 12:05:00 PM
- Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024 • PR Newswire (US) • 10/03/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 12:00:32 PM
- Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients • PR Newswire (US) • 09/27/2024 08:30:00 PM
- Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma • PR Newswire (US) • 09/16/2024 12:00:00 PM
- Poseida Therapeutics to Present New Clinical Data from Phase 1 Study of Allogeneic CAR-T P-BCMA-ALLO1 in Patients with Relapsed/Refractory Multiple Myeloma at 21st International Myeloma Society Annual Meeting • PR Newswire (US) • 09/05/2024 01:00:00 PM
- Poseida Therapeutics Presents New Case Study Demonstrating Reactivation of CAR-T Therapy with a T-Cell Engager in a Patient with Relapsed Multiple Myeloma • PR Newswire (US) • 09/04/2024 08:05:00 PM
Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM